07-122 | Anti-Kalirin Antibody

WB: Rat brain microsomal protein preparation was probed with anti-Kalirin (2μg/ml). Arrow indicates Kalirin (190kDa).
WB: Rat brain microsomal protein preparation was probed with anti-Kalirin (2μg/ml). Arrow indicates
200 µg  
Recuperando precio...
No pudo obtenerse el precio
Al finalizar el pedido Más información
Ahorró ()
Solicitar precio
Disponibilidad a confirmar Disponibilidad a confirmar
Cantidades limitadas disponibles
Debe confirmarse disponibilidad
      Se avisará

      Ofertas especiales


      Póngase en contacto con el Servicio de Atención al Cliente

         CompararClick To Print This Page


      Ofertas especiales

      Tabla espec. clave

      Reactividad según especiesAplicaciones claveHospedadorFormatoTipo de anticuerpo
      Rata, RatónInmunocitoquímica, Inmunoprecipitación, WBConejoPurificadoAnticuerpo policlonal
      Número de catálogo 07-122
      Marca de familia Upstate
      Nombre comercial
      • Upstate
      Descripción Anti-Kalirin Antibody
      Referencias bibliográficas
      Información del producto
      Formato Purificado
      Especificidad Kalirin; does not cross react with Trio
      Presentación 0.1M Tris-glycine, pH 7.4, 0.15M NaCl, 0.05% sodium azide prior to the addition of glycerol to 30%
      Aplicación Anti-Kalirin Antibody is an antibody against Kalirin for use in IP, WB & IC.
      Aplicaciones clave
      • Inmunocitoquímica
      • Inmunoprecipitación
      • Western Blotting
      Información biológica
      Especies inmunógenas GST fusion protein corresponding to residues 517-976 of rat Kalirin, cleaved with thrombin to remove the GST moiety; referred to as JH2582
      Hospedador Conejo
      Especificidad Kalirin; does not cross react with Trio
      Isotipo IgG
      Reactividad según especies Rata Ratón
      Tipo de anticuerpo Anticuerpo policlonal
      Número de Entrez Gene
      Resumen de Entrez Gene Huntington's disease (HD), a neurodegenerative disorder characterized by loss of striatal neurons, is caused by an expansion of a polyglutamine tract in the HD protein huntingtin. This gene encodes a protein that interacts with the huntingtin-associated protein 1, which is a huntingtin binding protein that may function in vesicle trafficking. Alternatively spliced transcript variants encoding different isoforms have been described.
      Símbolo de gen
      • HAPIP
      • KALRN
      • TRAD
      • Hs.8004
      • DUET
      • duo
      • Kalirin
      • FLJ16443
      • DUO
      Método de purificación Protein A chromatography
      Número UniProt
      Resumen UniProt FUNCTION: SwissProt: O60229 # Promotes the exchange of GDP by GTP. Activates specific Rho GTPase family members, thereby inducing various signaling mechanisms that regulate neuronal shape, growth, and plasticity, through their effects on the actin cytoskeleton. Induces lamellipodia independent of its GEF activity.
      COFACTOR: Magnesium.
      SIZE: 2985 amino acids; 340174 Da
      SUBUNIT: Interacts with the C-terminal of peptidylglycine alpha- amidating monooxygenase (PAM) and with the huntingtin-associated protein 1 (HAP1) (By similarity).
      SUBCELLULAR LOCATION: Cytoplasm. Cytoplasm, cytoskeleton. Note=Associated with the cytoskeleton.
      TISSUE SPECIFICITY: Isoform 2 is brain specific. Highly expressed in cerebral cortex, putamen, amygdala, hippocampus and caudate nucleus. Weakly expressed in brain stem and cerebellum. Isoform 4 is expressed in skeletal muscle.
      DOMAIN: SwissProt: O60229 The two GEF domains catalyze nucleotide exchange for RAC1 and RhoA which are bound by DH1 and DH2 respectively. The two GEF domains appear to play differing roles in neuronal development and axonal outgrowth. SH3 1 binds to the first GEF domain inhibiting GEF activity only when in the presence of a PXXP peptide, suggesting that the SH3 domain/peptide interaction mediates binding to GEF1. CRK1 SH3 domain binds to and inhibits GEF1 activity (By similarity).
      PTM: Autophosphorylated.
      DISEASE: SwissProt: O60229 # Genetic variation in KALRN is associated with susceptibility to coronary heart disease type 5 (CHDS5) [MIM:608901]. CHD is the leading cause of death and disability worldwide. CHD is multifactorial disease with a strong genetic component. Classic epidemiologic studies have revealed many risk factors for CHD, including age, sex, hypertension, dyslipidemia, diabetes mellitus, smoking, and physical inactivity.
      SIMILARITY: Belongs to the protein kinase superfamily. Ser/Thr protein kinase family. & Contains 1 CRAL-TRIO domain. & Contains 2 DH (DBL-homology) domains. & Contains 1 fibronectin type-III domain. & Contains 1 Ig-like C2-type (immunoglobulin-like) domain. & Contains 2 PH domains. & Contains 1 protein kinase domain. & Contains 1 RPR domain. & Contains 2 SH3 domains. & Contains 5 spectrin repeats.
      MISCELLANEOUS: Called DUO because the encoded protein is closely related to but shorter than TRIO.
      Información fisicoquímica
      Información de materiales
      Información toxicológica
      Información de seguridad según el GHS
      Información de seguridad
      Declaraciones de uso del producto
      Aseguramiento de calidad routinely evaluated by immunoblot on RIPA lysates from rat brain microsomal protein preparation; long exposure times may be required
      Declaración de uso
      • Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.
      Información de almacenamiento y transporte
      Condiciones de almacenamiento 2 years at -20°C
      Información sobre embalaje
      Tamaño material 200 µg
      Información de transporte
      Información complementaria


      Ficha datos de seguridad (MSDS)


      Certificados de análisis

      CargoNúmero de lote
      07-122 - 2280413 2280413
      Anti-Kalirin (rabbit polyclonal IgG) - 2015760 2015760
      Anti-Kalirin (rabbit polyclonal IgG) - 2032852 2032852
      Anti-Kalirin (rabbit polyclonal IgG) - 2155411 2155411
      Anti-Kalirin (rabbit polyclonal IgG) - 2332542 2332542
      Anti-Kalirin - 20095 20095
      Anti-Kalirin - 2043526 2043526
      Anti-Kalirin - DAM1576930 DAM1576930
      Anti-Kalirin - DAM1606754 DAM1606754
      Anti-Kalirin - DAM1647874 DAM1647874
      Anti-Kalirin - DAM1690659 DAM1690659
      Anti-Kalirin - NG1844879 NG1844879

      Referencias bibliográficas

      Visión general referenciasPub Med ID
      β-Amyloid 42/40 ratio and kalirin expression in Alzheimer disease with psychosis.
      Patrick S Murray,Caitlin M Kirkwood,Megan C Gray,Milos D Ikonomovic,William R Paljug,Eric E Abrahamson,Ruth A Henteleff,Ronald L Hamilton,Julia K Kofler,William E Klunk,Oscar L Lopez,Peter Penzes,Robert A Sweet
      Neurobiology of aging 33 2012

      Mostrar resumen
      Social, Communication, and Cortical Structural Impairments in Epac2-Deficient Mice.
      Srivastava, Deepak P, et al.
      J. Neurosci., 32: 11864-11878 (2012) 2012

      Mostrar resumen
      An isoform of kalirin, a brain-specific GDP/GTP exchange factor, is enriched in the postsynaptic density fraction.
      Penzes, P, et al.
      J. Biol. Chem., 275: 6395-403 (2000) 2000

      Mostrar resumen
      Kalirin inhibition of inducible nitric-oxide synthase.
      Ratovitski, E A, et al.
      J. Biol. Chem., 274: 993-9 (1999) 1999

      Mostrar resumen
      Kalirin, a multifunctional PAM COOH-terminal domain interactor protein, affects cytoskeletal organization and ACTH secretion from AtT-20 cells.
      Mains, R E, et al.
      J. Biol. Chem., 274: 2929-37 (1999) 1999

      Mostrar resumen